Patent · US Active

Pharmaceutical dosage forms

US10143680B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Stefania Beato · Verona, IT
Peggy Quinton · Mulhouse, FR

Key dates

Filing date	Jul 6, 2015
Grant date	Dec 4, 2018
Priority date	—
Expiry date	Jul 6, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P13/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to pharmaceutical dosage forms for oral administration comprising the drug substance 4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile or any pharmaceutically acceptable salt thereof and to processes of making said solid pharmaceutical dosage forms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.